Cargando…
An Italian Retrospective Survey on Bone Metastasis in Melanoma: Impact of Immunotherapy and Radiotherapy on Survival
BACKGROUND: We performed a multicenter retrospective observational study to investigate the impact of clinical–pathological features and therapeutic strategies on both the complications and survival of patients with bone metastases (BMs) from malignant melanoma. PATIENTS AND METHODS: A total of 305...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523509/ https://www.ncbi.nlm.nih.gov/pubmed/33042809 http://dx.doi.org/10.3389/fonc.2020.01652 |
_version_ | 1783588393349808128 |
---|---|
author | Mannavola, Francesco Mandala, Mario Todisco, Annalisa Sileni, Vanna Chiarion Palla, Marco Minisini, Alessandro Marco Pala, Laura Morgese, Francesca Di Guardo, Lorenza Stucci, Luigia Stefania Guida, Michele Indini, Alice Quaglino, Pietro Ferraresi, Virginia Marconcini, Riccardo Tronconi, Maria Chiara Rossi, Ernesto Nigro, Olga Occelli, Marcella Cortellini, Alessio Quadrini, Silvia Palmieri, Giuseppe Pigozzo, Jacopo Ascierto, Paolo Antonio Vitale, Maria Grazia Strippoli, Sabino Ferrucci, Pier Francesco Berardi, Rossana Randon, Giovanni Cardone, Pietro Schinzari, Giovanni Silvestris, Franco Tucci, Marco |
author_facet | Mannavola, Francesco Mandala, Mario Todisco, Annalisa Sileni, Vanna Chiarion Palla, Marco Minisini, Alessandro Marco Pala, Laura Morgese, Francesca Di Guardo, Lorenza Stucci, Luigia Stefania Guida, Michele Indini, Alice Quaglino, Pietro Ferraresi, Virginia Marconcini, Riccardo Tronconi, Maria Chiara Rossi, Ernesto Nigro, Olga Occelli, Marcella Cortellini, Alessio Quadrini, Silvia Palmieri, Giuseppe Pigozzo, Jacopo Ascierto, Paolo Antonio Vitale, Maria Grazia Strippoli, Sabino Ferrucci, Pier Francesco Berardi, Rossana Randon, Giovanni Cardone, Pietro Schinzari, Giovanni Silvestris, Franco Tucci, Marco |
author_sort | Mannavola, Francesco |
collection | PubMed |
description | BACKGROUND: We performed a multicenter retrospective observational study to investigate the impact of clinical–pathological features and therapeutic strategies on both the complications and survival of patients with bone metastases (BMs) from malignant melanoma. PATIENTS AND METHODS: A total of 305 patients with melanoma and radiological evidence of BMs were retrospectively enrolled from 19 Italian centers. All patients received conventional treatments in accordance with each own treating physician’s practice. Both univariate and multivariate models were used to explore the impact of melanoma features, including skeletal-related events (SREs), and different treatments on both overall survival (OS) and time-to-SREs. The chi-squared test evaluated the suitability of several parameters to predict the occurrence of SREs. RESULTS: Eighty-three percent of patients had metachronous BMs. The prevalent (90%) bone metastatic site was the spine, while 45% had involvement of the appendicular skeleton. Forty-seven percent experienced at least one SRE, including palliative radiotherapy (RT) in 37% of cases. No melanoma-associated factor was predictive of the development of SREs, although patients receiving early treatment with bone-targeted agents showed 62% lower risk and delayed time of SRE occurrence. Median OS from the diagnosis of bone metastasis was 10.7 months. The multivariate analysis revealed as independent prognostic factors the number of BMs, number of metastatic organs, baseline lactate dehydrogenase levels, and treatment with targeted therapy or immunotherapy. Subgroup analyses showed the best OS (median = 16.5 months) in the subset of patients receiving both immunotherapy and palliative RT. CONCLUSION: Based on our results, patients undergoing immunotherapy and palliative RT showed an OS benefit suggestive of a possible additive effect. The apparent protective role of bone targeting agent use on SREs observed in our analysis should deserve prospective evaluation. |
format | Online Article Text |
id | pubmed-7523509 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-75235092020-10-09 An Italian Retrospective Survey on Bone Metastasis in Melanoma: Impact of Immunotherapy and Radiotherapy on Survival Mannavola, Francesco Mandala, Mario Todisco, Annalisa Sileni, Vanna Chiarion Palla, Marco Minisini, Alessandro Marco Pala, Laura Morgese, Francesca Di Guardo, Lorenza Stucci, Luigia Stefania Guida, Michele Indini, Alice Quaglino, Pietro Ferraresi, Virginia Marconcini, Riccardo Tronconi, Maria Chiara Rossi, Ernesto Nigro, Olga Occelli, Marcella Cortellini, Alessio Quadrini, Silvia Palmieri, Giuseppe Pigozzo, Jacopo Ascierto, Paolo Antonio Vitale, Maria Grazia Strippoli, Sabino Ferrucci, Pier Francesco Berardi, Rossana Randon, Giovanni Cardone, Pietro Schinzari, Giovanni Silvestris, Franco Tucci, Marco Front Oncol Oncology BACKGROUND: We performed a multicenter retrospective observational study to investigate the impact of clinical–pathological features and therapeutic strategies on both the complications and survival of patients with bone metastases (BMs) from malignant melanoma. PATIENTS AND METHODS: A total of 305 patients with melanoma and radiological evidence of BMs were retrospectively enrolled from 19 Italian centers. All patients received conventional treatments in accordance with each own treating physician’s practice. Both univariate and multivariate models were used to explore the impact of melanoma features, including skeletal-related events (SREs), and different treatments on both overall survival (OS) and time-to-SREs. The chi-squared test evaluated the suitability of several parameters to predict the occurrence of SREs. RESULTS: Eighty-three percent of patients had metachronous BMs. The prevalent (90%) bone metastatic site was the spine, while 45% had involvement of the appendicular skeleton. Forty-seven percent experienced at least one SRE, including palliative radiotherapy (RT) in 37% of cases. No melanoma-associated factor was predictive of the development of SREs, although patients receiving early treatment with bone-targeted agents showed 62% lower risk and delayed time of SRE occurrence. Median OS from the diagnosis of bone metastasis was 10.7 months. The multivariate analysis revealed as independent prognostic factors the number of BMs, number of metastatic organs, baseline lactate dehydrogenase levels, and treatment with targeted therapy or immunotherapy. Subgroup analyses showed the best OS (median = 16.5 months) in the subset of patients receiving both immunotherapy and palliative RT. CONCLUSION: Based on our results, patients undergoing immunotherapy and palliative RT showed an OS benefit suggestive of a possible additive effect. The apparent protective role of bone targeting agent use on SREs observed in our analysis should deserve prospective evaluation. Frontiers Media S.A. 2020-09-15 /pmc/articles/PMC7523509/ /pubmed/33042809 http://dx.doi.org/10.3389/fonc.2020.01652 Text en Copyright © 2020 Mannavola, Mandala, Todisco, Sileni, Palla, Minisini, Pala, Morgese, Di Guardo, Stucci, Guida, Indini, Quaglino, Ferraresi, Marconcini, Tronconi, Rossi, Nigro, Occelli, Cortellini, Quadrini, Palmieri, Pigozzo, Ascierto, Vitale, Strippoli, Ferrucci, Berardi, Randon, Cardone, Schinzari, Silvestris and Tucci. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Mannavola, Francesco Mandala, Mario Todisco, Annalisa Sileni, Vanna Chiarion Palla, Marco Minisini, Alessandro Marco Pala, Laura Morgese, Francesca Di Guardo, Lorenza Stucci, Luigia Stefania Guida, Michele Indini, Alice Quaglino, Pietro Ferraresi, Virginia Marconcini, Riccardo Tronconi, Maria Chiara Rossi, Ernesto Nigro, Olga Occelli, Marcella Cortellini, Alessio Quadrini, Silvia Palmieri, Giuseppe Pigozzo, Jacopo Ascierto, Paolo Antonio Vitale, Maria Grazia Strippoli, Sabino Ferrucci, Pier Francesco Berardi, Rossana Randon, Giovanni Cardone, Pietro Schinzari, Giovanni Silvestris, Franco Tucci, Marco An Italian Retrospective Survey on Bone Metastasis in Melanoma: Impact of Immunotherapy and Radiotherapy on Survival |
title | An Italian Retrospective Survey on Bone Metastasis in Melanoma: Impact of Immunotherapy and Radiotherapy on Survival |
title_full | An Italian Retrospective Survey on Bone Metastasis in Melanoma: Impact of Immunotherapy and Radiotherapy on Survival |
title_fullStr | An Italian Retrospective Survey on Bone Metastasis in Melanoma: Impact of Immunotherapy and Radiotherapy on Survival |
title_full_unstemmed | An Italian Retrospective Survey on Bone Metastasis in Melanoma: Impact of Immunotherapy and Radiotherapy on Survival |
title_short | An Italian Retrospective Survey on Bone Metastasis in Melanoma: Impact of Immunotherapy and Radiotherapy on Survival |
title_sort | italian retrospective survey on bone metastasis in melanoma: impact of immunotherapy and radiotherapy on survival |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523509/ https://www.ncbi.nlm.nih.gov/pubmed/33042809 http://dx.doi.org/10.3389/fonc.2020.01652 |
work_keys_str_mv | AT mannavolafrancesco anitalianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT mandalamario anitalianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT todiscoannalisa anitalianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT silenivannachiarion anitalianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT pallamarco anitalianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT minisinialessandromarco anitalianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT palalaura anitalianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT morgesefrancesca anitalianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT diguardolorenza anitalianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT stucciluigiastefania anitalianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT guidamichele anitalianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT indinialice anitalianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT quaglinopietro anitalianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT ferraresivirginia anitalianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT marconciniriccardo anitalianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT tronconimariachiara anitalianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT rossiernesto anitalianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT nigroolga anitalianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT occellimarcella anitalianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT cortellinialessio anitalianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT quadrinisilvia anitalianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT palmierigiuseppe anitalianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT pigozzojacopo anitalianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT asciertopaoloantonio anitalianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT vitalemariagrazia anitalianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT strippolisabino anitalianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT ferruccipierfrancesco anitalianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT berardirossana anitalianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT randongiovanni anitalianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT cardonepietro anitalianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT schinzarigiovanni anitalianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT silvestrisfranco anitalianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT tuccimarco anitalianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT mannavolafrancesco italianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT mandalamario italianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT todiscoannalisa italianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT silenivannachiarion italianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT pallamarco italianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT minisinialessandromarco italianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT palalaura italianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT morgesefrancesca italianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT diguardolorenza italianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT stucciluigiastefania italianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT guidamichele italianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT indinialice italianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT quaglinopietro italianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT ferraresivirginia italianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT marconciniriccardo italianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT tronconimariachiara italianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT rossiernesto italianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT nigroolga italianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT occellimarcella italianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT cortellinialessio italianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT quadrinisilvia italianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT palmierigiuseppe italianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT pigozzojacopo italianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT asciertopaoloantonio italianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT vitalemariagrazia italianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT strippolisabino italianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT ferruccipierfrancesco italianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT berardirossana italianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT randongiovanni italianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT cardonepietro italianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT schinzarigiovanni italianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT silvestrisfranco italianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival AT tuccimarco italianretrospectivesurveyonbonemetastasisinmelanomaimpactofimmunotherapyandradiotherapyonsurvival |